BTIG Reiterates Neutral Rating on Bionano Genomics (BNGO)

Go back to BTIG Reiterates Neutral Rating on Bionano Genomics (BNGO)

Ladenburg Thalmann Downgrades Bionano Genomics (BNGO) to Neutral

November 15, 2024 6:42 AM EST

Ladenburg Thalmann analyst Jeffrey Cohen downgraded Bionano Genomics (NASDAQ: BNGO) from Buy to Neutral.

For an analyst ratings summary and ratings history on Bionano Genomics click here. For more ratings news on Bionano Genomics click here.

Shares of Bionano Genomics closed at $0.26 yesterday.

... More